MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,585 | +16.3% | 16,124 | +68.1% | 0.00% | – |
| Q2 2023 | $222,328 | +3.9% | 9,593 | +4.1% | 0.00% | – |
| Q1 2023 | $213,980 | -33.3% | 9,213 | -58.3% | 0.00% | -100.0% |
| Q4 2022 | $320,785 | -23.1% | 22,103 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $417,000 | +10.0% | 21,815 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $379,000 | -22.3% | 20,824 | +7.5% | 0.00% | 0.0% |
| Q1 2022 | $488,000 | +3.4% | 19,365 | +13.3% | 0.00% | 0.0% |
| Q4 2021 | $472,000 | -35.0% | 17,093 | -24.1% | 0.00% | -50.0% |
| Q3 2021 | $726,000 | +31.8% | 22,511 | +25.2% | 0.00% | +100.0% |
| Q2 2021 | $551,000 | -9.5% | 17,987 | -10.0% | 0.00% | 0.0% |
| Q1 2021 | $609,000 | +128.9% | 19,975 | +48.3% | 0.00% | 0.0% |
| Q4 2020 | $266,000 | +44.6% | 13,471 | -4.4% | 0.00% | 0.0% |
| Q3 2020 | $184,000 | +13.6% | 14,089 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $162,000 | +19.1% | 14,300 | +50.8% | 0.00% | 0.0% |
| Q1 2020 | $136,000 | – | 9,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |